- Available Activity:

- In Progress:

- Completed:

- Saved:

Best Practices in Diagnosis and Multimodal Management of Fibromyalgia (Part One of a Two Part Series)
A Fibromyalgia Working Group was convened to integrate published evidence and expert opinion into best practice recommendations around multidimensional assessment and multimodal treatment of patients with fibromyalgia. Here, Working Group chair Charles E. Argoff, MD provides his insights into...
Best Practices in Diagnosis and Multimodal Management of Fibromyalgia (Part Two of a Two Part Series)
A Fibromyalgia Working Group was convened to integrate published evidence and expert opinion into best practice recommendations around the multidimensional assessment and multimodal treatment of patients with fibromyalgia. Here, Working Group member I Jon Russell, MD, PhD provides his insights...
Opioids and Pain What Does The Evidence Mean?
Dr Portenoy discusses foundations of evidence-based medicine, appropriate use of opioid pharmacotherapy for persistent and breakthrough pain, and considerations for treating chronic pain in cancer survivors.
Chronic Pain in Cancer Survivors: Determinants, Assessment, and Treatment Strategies
Dr Brennan discusses foundations of evidence-based medicine, appropriate use of opioid pharmacotherapy for persistent and breakthrough pain, and considerations for treating chronic pain in cancer survivors.
Clinical Aspects of Risk Management in Opioid Prescribing
Dr Passik discusses foundations of evidence-based medicine, appropriate use of opioid pharmacotherapy for persistent and breakthrough pain, and considerations for treating chronic pain in cancer survivors.
Controlling Baseline Pain With Opioid-based Therapy (Part 1 of 3)
Michael J. Brennan, MD, from the Pain Center of Fairfield in Fairfield, Connecticut, leads a discussion on best practices in the formulation and ongoing refinement of opioid-based therapeutic plans for presistent and breakthrough pain.
Assessing and Treating Breakthrough Pain (Part 2 of 3)
Perry G. Fine, MD, of the University of Utah School of Medicine in Salt Lake City, shares his views on differentially diagnosing breakthrough pain, including implications for nonpharmacologic and pharmacologic treatment strategies.
Practical Approaches to Multidimensional Assessment and Opioid-Based Treatment of Chronic Pain (Part 3 of 3)
David M. Simpson, MD, MPH, from Mount Sinai Medical Center in New York City, explores chronic pain as a chronic disease and methods to talk to patients about daily variations in pain levels, responsible medication use, and treatment outcomes.
Persistent And Breakthrough Pain: Multidimensional Assessment and Opioid-Based Multimodal Treatment
Representative case studies provide an avenue to discuss current approaches to the clinical evaluation, diagnosis, and opioid-based management of patients with persistent and breakthrough pain
Persistent and Breakthrough Pain in Cancer Survivors: Multidimensional Assessment and Opioid-Based Multimodal Treatment
Russell K. Portenoy, MD, Michael J. Brennan, MD, and Steven D. Passik, PhD, discuss foundations of evidence-based medicine, appropriate use of opioid pharmacotherapy for persistent and breakthrough pain, and considerations for treating chronic pain in cancer survivors.
Welcome to the PAINClinician.com Education Page. Please take part in the Free CME activities being offered.
|
Association Links
|
e-Newsletter
|








